From: Inappropriate use of antibiotics for childhood diarrhea case management — Kenya, 2009–2016
Factors | Antibiotic prescribed (%) | Antibiotic not prescribed (%) | Crude odds ratio (95% CI) | Adjustedb odds ratio (95% CI) |
---|---|---|---|---|
Demographics | ||||
â€Çã²µ±ð &±ô³Ù; 1 | 29/90 (32.2%) | 12/33 (36.4%) | 1.20 (0.52–2.77) | Ìý |
 M²¹±ô±ð | 50/90 (55.6%) | 13/33 (39.4%) | 0.52 (0.23–1.17) | Ìý |
Recent medical history | ||||
 Clinic visit within 14 days | 8/90 (8.9%) | 3/33 (9.1%) | 1.03 (0.26–4.12) | Ìý |
 Clinic visit within 14 days with diarrheal symptom | 4/90 (4.4%) | 1/33 (3.0%) | 0.67 (0.07–6.24) | Ìý |
 Clinic visit within 14 days with antibiotic treatment | 5/90 (5.6%) | 0/33 (0%) | N/A | Ìý |
Signs and symptoms | ||||
 W±ð¾±²µ³ó³Ù-´Ú´Ç°ù-²¹²µ±ð &±ô³Ù; −2 | 17/89 (19.1%) | 9/33 (27.3%) | 1.59 (0.63–4.03) | Ìý |
‽ö±ð¾±²µ³ó³Ù-´Ú´Ç°ù-²¹²µ±ð &±ô³Ù; −2 | 22/85 (25.9%) | 6/30 (20.0%) | 0.72 (0.26–1.98) | Ìý |
 W±ð¾±²µ³ó³Ù-´Ú´Ç°ù-³ó±ð¾±²µ³ó³Ù &±ô³Ù; −2 | 14/85 (16.5%) | 5/30 (16.7%) | 1.02 (0.33–3.10) | Ìý |
 Measured or reported fever | 81/90 (90.0%) | 31/33 (93.9%) | 1.72 (0.35–8.42) | Ìý |
 C´Ç³Ü²µ³ó | 54/90 (60.0%) | 22/33 (66.7%) | 1.33 (0.58–3.08) | Ìý |
 Difficulty breathing | 1 /90 (1.1%) | 0/33 (0%) | N/A | Ìý |
 Sore throat | 1/89 (0.9%) | 0/32 (0%) | N/A | Ìý |
 V´Ç³¾¾±³Ù¾±²Ô²µ | 23/90 (25.6%) | 18/33 (54.5%) | 3.50 (1.52–8.04) | 4.36 (1.98–9.57) |
 Runny nose | 27/90 (30.0%) | 10/33 (30.3%) | 1.02 (0.43–2.42) | Ìý |
â€ÇȲԱð±ð³ú¾±²Ô²µ | 13/90 (14.4%) | 6/33 (18.2%) | 1.32 (0.46–3.81) | Ìý |
Physical examination | ||||
 Restless or irritable | 7/90 (7.8%) | 2/33 (6.1%) | 0.77 (0.15–3.88) | Ìý |
 Sunken eyes | 8/90 (8.9%) | 3/33 (12.1%) | 1.41 (0.40–5.05) | Ìý |
 Drinks eagerly, thirsty | 4/90 (4.4%) | 1/33 (3.0%) | 0.67 (0.07–6.24) | Ìý |
 Skin tenting | 4/90 (4.4%) | 0/33 (0%) | N/A | Ìý |
 Signs of anemia | 4/88 (4.6%) | 0/32 (0%) | N/A | Ìý |
 C°ù²¹³¦°ì±ô±ð²õ/°ù²¹±ô±ð²õ | 0/90 (0%) | 0/33 (0%) | N/A | Ìý |
Clinical diagnoses | ||||
 G²¹²õ³Ù°ù´Ç±ð²Ô³Ù±ð°ù¾±³Ù¾±²õ | 42/90 (45.6%) | 10/33 (30.3%) | 0.52 (0.22–1.22) | Ìý |
 Malaria diagnosis | 29/90 (32.2%) | 18/33 (54.6%) | 2.52 (1.12–5.71) | 1.82 (1.05–3.13) |
 D±ð³ó²â»å°ù²¹³Ù¾±´Ç²Ô | 3/90 (3.3%) | 3/33 (9.1%) | 2.90 (0.56–15.13) | Ìý |
 U¸é°Õ±õa | 20/90 (22.2%) | 8/33 (24.2%) | 1.12 (0.44–2.86) | Ìý |
 D²â²õ±ð²Ô³Ù±ð°ù²â | 47/90 (52.2%) | 8/33 (24.2%) | 0.29 (0.12–0.72) | 0.30 (0.07–1.24) |
Treatment | ||||
 Concurrent ORSa | 59/90 (65.6%) | 14/33 (42.4%) | 0.39 (0.17–0.88) | 0.34 (0.10–1.19) |
 Concurrent zinc | 41/90 (45.6%) | 15/33 (45.5%) | 1.00 (0.45–2.22) | Ìý |